SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891092-04-000307
Filing Date
2004-01-27
Accepted
2004-01-27 08:33:48
Documents
7
Period of Report
2004-01-27
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e16705_8k.txt 8-K 7265
3 SECURITIES AGREEMENT PURCHASE e16705ex10_1.txt EX-10.1 136490
4 DEBENTURE e16705ex10_2.txt EX-10.2 188953
5 FORM OF WARRANT e16705ex10_3.txt EX-10.3 71660
6 FORM OF WARRANT e16705ex10_4.txt EX-10.4 71253
7 REGISTRATION RIGHTS AGREEMENT e16705ex10_5.txt EX-10.5 71540
8 ADDITIONAL INVESTMENT RIGHT e16705ex10_6.txt EX-10.6 223434
  Complete submission text file 0000891092-04-000307.txt   772970
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 04544716
SIC: 2836 Biological Products, (No Diagnostic Substances)